www.newtimespace.com
网页
综合
Going Global | Chinese Companies Abroad | NewTimeSpace
… accepted in Europe and Japan, backed by the SAFFRON trial. On 30 October 2026, BOAN BIOTECH (06955.HK) struck a licensing deal for its denosumab 60mg (BA6101) in Japan, gaining upfront, mil…
2026-11-15
自动蜘蛛
相关度 4.4